162 related articles for article (PubMed ID: 35932584)
1. Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.
Albrecht F; Poulakis K; Freidle M; Johansson H; Ekman U; Volpe G; Westman E; Pereira JB; Franzén E
Parkinsonism Relat Disord; 2022 Sep; 102():19-29. PubMed ID: 35932584
[TBL] [Abstract][Full Text] [Related]
2. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
[TBL] [Abstract][Full Text] [Related]
3. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
[TBL] [Abstract][Full Text] [Related]
4. Brain connectivity for subtypes of parkinson's disease using structural MRI.
Samantaray T; Saini J; Pal PK; Gupta CN
Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38224618
[No Abstract] [Full Text] [Related]
5. Clinically relevant connectivity features define three subtypes of Parkinson's disease patients.
Guo T; Guan X; Zhou C; Gao T; Wu J; Song Z; Xuan M; Gu Q; Huang P; Pu J; Zhang B; Cui F; Xia S; Xu X; Zhang M
Hum Brain Mapp; 2020 Oct; 41(14):4077-4092. PubMed ID: 32588952
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
[TBL] [Abstract][Full Text] [Related]
7. A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment.
Aracil-Bolaños I; Sampedro F; Marín-Lahoz J; Horta-Barba A; Martínez-Horta S; Botí M; Pérez-Pérez J; Bejr-Kasem H; Pascual-Sedano B; Campolongo A; Izquierdo C; Gironell A; Gómez-Ansón B; Kulisevsky J; Pagonabarraga J
Hum Brain Mapp; 2019 Aug; 40(11):3233-3242. PubMed ID: 30938027
[TBL] [Abstract][Full Text] [Related]
8. Identifying and validating subtypes of Parkinson's disease based on multimodal MRI data
Cao K; Pang H; Yu H; Li Y; Guo M; Liu Y; Fan G
Front Hum Neurosci; 2022; 16():919081. PubMed ID: 35966989
[TBL] [Abstract][Full Text] [Related]
9. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
Goldman JG; Weis H; Stebbins G; Bernard B; Goetz CG
Mov Disord; 2012 Aug; 27(9):1129-36. PubMed ID: 22778009
[TBL] [Abstract][Full Text] [Related]
10. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
11. Gray and white matter alterations in different predominant side and type of motor symptom in Parkinson's disease.
Chen J; Jiang X; Wu J; Wu H; Zhou C; Guo T; Bai X; Liu X; Wen J; Cao Z; Gu L; Yang W; Pu J; Guan X; Xu X; Zhang B; Zhang M
CNS Neurosci Ther; 2022 Sep; 28(9):1372-1379. PubMed ID: 35673762
[TBL] [Abstract][Full Text] [Related]
12. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
[TBL] [Abstract][Full Text] [Related]
13. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
Zhang X; Chou J; Liang J; Xiao C; Zhao Y; Sarva H; Henchcliffe C; Wang F
Sci Rep; 2019 Jan; 9(1):797. PubMed ID: 30692568
[TBL] [Abstract][Full Text] [Related]
14. Sex Differences in Brain Structure in de novo Parkinson's Disease: A Cross-Sectional and Longitudinal Neuroimaging Study.
Li H; Jia X; Chen M; Jia X; Yang Q
J Parkinsons Dis; 2023; 13(5):785-795. PubMed ID: 37248914
[TBL] [Abstract][Full Text] [Related]
15. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
[TBL] [Abstract][Full Text] [Related]
16. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
17. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment.
Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G
Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411
[TBL] [Abstract][Full Text] [Related]
18. Brain structural and functional connectivity in Parkinson's disease with freezing of gait.
Canu E; Agosta F; Sarasso E; Volontè MA; Basaia S; Stojkovic T; Stefanova E; Comi G; Falini A; Kostic VS; Gatti R; Filippi M
Hum Brain Mapp; 2015 Dec; 36(12):5064-78. PubMed ID: 26359798
[TBL] [Abstract][Full Text] [Related]
19. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
Hall JM; Lewis SJG
Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
[TBL] [Abstract][Full Text] [Related]
20. Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease.
Wolters AF; Moonen AJH; Lopes R; Leentjens AFG; Duits AA; Defebvre L; Delmaire C; Hofman PA; van Bussel FC; Dujardin K
Cortex; 2020 Feb; 123():1-11. PubMed ID: 31733342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
